These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 2713086
1. Interaction of tetrahydropapaveroline with inhibition of dopa-decarboxylase by Ro 4-4602 in brain: effects on alcohol drinking in the rat. Miñano FJ, McMillen BA, Myers RD. Alcohol; 1989; 6(2):133-7. PubMed ID: 2713086 [Abstract] [Full Text] [Related]
2. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide. Miñano FJ, Myers RD. Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790 [Abstract] [Full Text] [Related]
3. Anatomical mapping of tetrahydropapaveroline-reactive sites in brain mediating suppression of alcohol drinking in the rat. Privette TH, Myers RD. Brain Res Bull; 1989 Jun; 22(6):1039-48. PubMed ID: 2790497 [Abstract] [Full Text] [Related]
4. A neuroanatomical substrate for alcohol drinking: identification of tetrahydropapaveroline (THP)-reactive sites in the rat brain. Myers RD, Privette TH. Brain Res Bull; 1989 May; 22(5):899-911. PubMed ID: 2765949 [Abstract] [Full Text] [Related]
5. Central action of an inhibitor of brain dopa-decarboxylase, NSD-1015, on cyanamide-induced alcohol drinking in rats. Miñano FJ, McMillen BA, Myers RD. Pharmacol Biochem Behav; 1990 Feb; 35(2):465-8. PubMed ID: 2320657 [Abstract] [Full Text] [Related]
6. Alcohol drinking induced in the monkey by tetrahydropapaveroline (THP) infused into the cerebral ventricle. Myers RD, McCaleb ML, Ruwe WD. Pharmacol Biochem Behav; 1982 Jun; 16(6):995-1000. PubMed ID: 7111356 [Abstract] [Full Text] [Related]
7. Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV. Myers RD, Critcher EC. Pharmacol Biochem Behav; 1982 May; 16(5):827-36. PubMed ID: 6283568 [Abstract] [Full Text] [Related]
9. Drinking patterns in genetic low-alcohol-drinking (LAD) rats after systemic cyanamide and cerebral injections of THP or 6-OHDA. West MW, Biggs TA, Tavares E, Lankford MF, Myers RD. Alcohol; 1998 Apr; 15(3):239-47. PubMed ID: 9539382 [Abstract] [Full Text] [Related]
10. A re-evaluation of the role of tetrahydropapaveroline in ethanol consumption in rats. McCoy JG, Strawbridge C, McMurtrey KD, Kane VB, Ward CP. Brain Res Bull; 2003 Apr 15; 60(1-2):59-65. PubMed ID: 12725893 [Abstract] [Full Text] [Related]
11. Cerebroventricular tetrahydropapaveroline infusions and ethanol consumption in the rat. Sinclair JD, Myers RD. Subst Alcohol Actions Misuse; 1982 Apr 15; 3(1-2):5-24. PubMed ID: 6890240 [Abstract] [Full Text] [Related]
12. Preference for alcohol evoked by tetrahydropapaveroline (THP) chronically infused in the cerebral ventricle of the rat. Melchior CL, Myers RD. Pharmacol Biochem Behav; 1977 Jul 15; 7(1):19-35. PubMed ID: 561961 [No Abstract] [Full Text] [Related]
13. A critical evaluation of tetrahydroisoquinoline induced ethanol preference in rats. Duncan C, Deitrich RA. Pharmacol Biochem Behav; 1980 Aug 15; 13(2):265-81. PubMed ID: 7413698 [Abstract] [Full Text] [Related]
14. The effect of tetrahydropapaveroline and naltrexone on voluntary ethanol ingestion in rats. Oster L, Martinez TT. Proc West Pharmacol Soc; 1988 Aug 15; 31():277-9. PubMed ID: 3211915 [No Abstract] [Full Text] [Related]
15. Tetrahydropapaveroline and salsolinol alter 45Ca2+ efflux within perfused hippocampus of unrestrained rats. Myers RD, Privette TH, Hornsby RL, Swartzwelder HS. Neurochem Res; 1988 Oct 15; 13(10):989-95. PubMed ID: 3216956 [Abstract] [Full Text] [Related]
18. Ethanol preference in rats: increased consumption after intraventricular administration of tetrahydropapaveroline. Clow A, Stolerman IP, Murray RM, Sandler M. Neuropharmacology; 1983 Apr 29; 22(4):563-5. PubMed ID: 6856052 [No Abstract] [Full Text] [Related]
19. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites. Alachkar A, Brotchie JM, Jones OT. Neurosci Res; 2010 Sep 29; 68(1):44-50. PubMed ID: 20542064 [Abstract] [Full Text] [Related]
20. Blockade of 5-HTp reduction of ethanol drinking with the decarboxylase inhibitor, ro 4-4602. Geller I, Hartmann RJ, Messiha FS. Pharmacol Biochem Behav; 1981 Dec 29; 15(6):871-4. PubMed ID: 6976579 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]